Selective targeting of lysosomal cysteine proteases with radiolabeled electrophilic substrate analogs.
暂无分享,去创建一个
S Toba | M. Bogyo | D. Greenbaum | M Bogyo | S. Verhelst | S Verhelst | V Bellingard-Dubouchaud | D Greenbaum | S. Toba | V. Bellingard-Dubouchaud | Matthew Bogyo | Valerie Bellingard-Dubouchaud | Sam Toba
[1] N. Katunuma,et al. Novel epoxysuccinyl peptides A selective inhibitor of cathepsin B, in vivo , 1991, FEBS letters.
[2] R. Mason,et al. Control of breast tumor cell growth using a targeted cysteine protease inhibitor. , 1998, Cancer research.
[3] D. Rich,et al. Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. , 1992, The Journal of biological chemistry.
[4] K. Lim,et al. Integrin switching regulates normal trophoblast invasion. , 1994, Development.
[5] William N. Kelley,et al. Textbook of rheumatology , 1985 .
[6] J. Gasteiger,et al. ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES , 1980 .
[7] C. Damsky,et al. Trophoblast pseudo-vasculogenesis: faking it with endothelial adhesion receptors. , 1998, Current opinion in cell biology.
[8] T. Schirmeister,et al. Cysteine Proteases and Their Inhibitors. , 1997, Chemical reviews.
[9] N. Katunuma,et al. Switch of CD4+ T cell differentiation from Th2 to Th1 by treatment with cathepsin B inhibitor in experimental leishmaniasis. , 1998, Journal of immunology.
[10] J. Palmer,et al. Vinyl sulfones as mechanism-based cysteine protease inhibitors. , 1995, Journal of medicinal chemistry.
[11] H. Mcdevitt,et al. The LMP antigens: a stable MHC-controlled multisubunit protein complex. , 1986, Human immunology.
[12] Z. Werb,et al. 92-kD type IV collagenase mediates invasion of human cytotrophoblasts , 1991, The Journal of cell biology.
[13] H. Chapman,et al. Emerging roles for cysteine proteases in human biology. , 1997, Annual review of physiology.
[14] A. Barrett,et al. CA074 methyl ester: a proinhibitor for intracellular cathepsin B. , 1992, Archives of biochemistry and biophysics.
[15] D. Rich,et al. Mechanistic studies on the inactivation of papain by epoxysuccinyl inhibitors. , 1996, Journal of medicinal chemistry.
[16] H. Chapman,et al. Endosomal proteolysis and MHC class II function. , 1998, Current opinion in immunology.
[17] R. Mason,et al. Quantification of cathepsins B and L in cells. , 1998, The Biochemical journal.
[18] A. Goldberg,et al. Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[19] Sunny Shin,et al. Substrate binding and sequence preference of the proteasome revealed by active-site-directed affinity probes. , 1998, Chemistry & biology.
[20] J. Palmer,et al. Peptidyl vinyl sulphones: a new class of potent and selective cysteine protease inhibitors: S2P2 specificity of human cathepsin O2 in comparison with cathepsins S and L. , 1996, The Biochemical journal.
[21] R. Mason,et al. Design of a transferrin-proteinase inhibitor conjugate to probe for active cysteine proteinases in endosomes. , 1998, The Biochemical journal.
[22] Human placenta protein-tyrosine-phosphatase: amino acid sequence and relationship to a family of receptor-like proteins , 1989 .
[23] E. Dejana,et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? , 1997, The Journal of clinical investigation.
[24] G. Zhang,et al. Adhesive and degradative properties of human placental cytotrophoblast cells in vitro , 1989, The Journal of cell biology.
[25] I. Kuntz,et al. Inclusion of Solvation in Ligand Binding Free Energy Calculations Using the Generalized-Born Model , 1999 .
[26] N. Katunuma,et al. Abnormal expression of lysosomal cysteine proteinases in muscle wasting diseases. , 1987, Reviews of physiology, biochemistry and pharmacology.
[27] R. Ménard,et al. Epoxysuccinyl dipeptides as selective inhibitors of cathepsin B. , 1993, Journal of medicinal chemistry.
[28] N. Katunuma,et al. Novel physiological functions of cathepsins B and L on antigen processing and osteoclastic bone resorption. , 1998, Advances in enzyme regulation.
[29] R. Huber,et al. Crystal structure of cathepsin B inhibited with CA030 at 2.0-A resolution: A basis for the design of specific epoxysuccinyl inhibitors. , 1995, Biochemistry.
[30] E. Shaw,et al. The identification of active forms of cysteine proteinases in Kirsten-virus-transformed mouse fibroblasts by use of a specific radiolabelled inhibitor. , 1989, The Biochemical journal.
[31] R. Mitchell,et al. Cathepsin S activity regulates antigen presentation and immunity. , 1998, The Journal of clinical investigation.
[32] P. Kollman,et al. A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .
[33] T Vernet,et al. Role of the Occluding Loop in Cathepsin B Activity* , 1997, The Journal of Biological Chemistry.
[34] E. Shaw,et al. Cysteinyl proteinases and their selective inactivation. , 1990, Advances in enzymology and related areas of molecular biology.
[35] M. Murata,et al. Novel epoxysuccinyl peptides Selective inhibitors of cathepsin B, in vitro , 1991, FEBS letters.